# International Flavors & Fragrances Inc. – Consensus ‘buy’ rating and 2.5% Upside Potential

- Link: https://www.directorstalkinterviews.com/international-flavors-fragrances-inc.consensus-buy-rating-and-2.5-upside-potential/4121160857
- Published: 2024-06-19T16:08:56+01:00
- Author: Charlotte Edwards

**International Flavors & Fragrances Inc.** which can be found using ticker (IFF)
have now 20 analysts in total covering the stock. The consensus rating is pointing
to ‘buy’. The range between the high target price and low target price is between
$116.00 and $70.00 suggesting an average Analsyt target price of $97.16. Given that
the stocks previous close was at $94.80 and the analysts are correct then we can
expect a percentage increase in value of 2.5%. Also worth taking note is the 50 
day moving average now sits at $91.91 while the 200 day moving average is $79.66.
The total market capitalization for the company now stands at 24.55B. The stock 
price is currently at: $96.14 USD

 The potential market cap would be $25,160,592,169 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $44.51 and
a 1.19% return on assets.

International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage,
health and biosciences, scent and pharma solutions and complementary adjacent products.
The Company’s segments include Nourish, Health & Biosciences, Scent and Pharma Solutions.
The Nourish segment comprises of ingredients, flavors and food designs, with a diversified
portfolio across natural and plant-based specialty food ingredients, flavor compounds,
and savory solutions and inclusions. The Health & Biosciences comprises of health,
cultures and food enzymes, home and personal care, animal nutrition and grain processing.
The Scent segment comprises of fragrance compounds, including fine fragrances and
consumer fragrances; fragrance ingredients, and cosmetic active ingredients. The
Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-
based pharmaceutical excipients, used to improve the functionality and delivery 
of active pharmaceutical ingredients.

Share on:
